Medtronic Infuse Lawsuits Over Bone Growth Complications Top 1,000

Medtronic faces about 1,000 product liability lawsuits involving problems with the Infuse bone graft device, where plaintiffs allege that they experienced complications associated with bone overgrowth after the device was implanted in their spines during procedures that were not approved by the FDA.

Medtronic Infuse is a newer type of bio-engineered bone graft product that has been promoted as an alternative to traditional spinal fusions, where bone is harvested from another area of the body or used from a cadaver.

The FDA approved Infuse recombinant human bone morphogenetic protein (rhBMP-2) for limited use during spinal fusion procedures where the lumbar spine is approached through the front and the product is applied to an absorbable collagen sponge that is placed within an “LT-Cage” that is implanted to encourage bone growth and fuse the gaps between the vertebrae. However, Medtronic has been accused of illegally promoting the device for non-approved uses, with a vast majority of sales for Infuse involving applications that were never approved by the FDA.

Did You Know? Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

On March 3, Medtronic released a report for the third quarter of fiscal year 2014 (PDF) indicating that more than 1,000 people have presented claims against the company in state and federal courts nationwide, and the number of complaints is expected to continue to grow significantly.

According to allegations raised in the Medtronic Infuse bone graft lawsuits, plaintiffs have suffered severe never damage, airway comprssion and other complications associated with uncontrollable bone growth after the device was used off-label, such as in the cervical spine, at multiple levels or through a non-anterior approach.

Medtronic has tried repeatedly to have the cases dismissed, arguing that the product liability lawsuits should be pre-empted by federal law because the Infuse device was approved by the FDA. The manufacturer has argued that the controversial Supreme Court decision in Riegel v. Medtronic should be applied to protect them from design defect claims, but plaintiffs claim that the company loses that protection because it illegally marketed Infuse for uses not approved by the FDA.

Medtronic has been accused of withholding important safety information about the risks associated with off-label uses, resulting in an argument by plaintiffs that the claims should therefore not be subject to the Supreme Court decision that state-law product liability claims involving approved medical devices are preempted by federal law.

federal judge rejected the company’s pre-emption argument in August, allowing some cases to proceed. However, unlike many similar litigation, the Medtronic Infuse lawsuits have not been centralized in federal court, which means each case is going through pretrial proceedings individually, increasing the chances of contradictory rulings by different judges.

Image Credit: |


  • LindaJuly 25, 2021 at 3:58 am

    I'm trying to find an attorney to help me regarding bone overgrowth from off-label use of INFUSE bone graft. However I am not having much luck. I am in Minnesota. Is any reader out there aware of anyone? It seems that Medtronics is so big that attorneys won't fight them on this. Thank you

"*" indicates required fields

Share Your Comments

I authorize the above comments be posted on this page*

Have Your Comments Reviewed by a Lawyer

Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Camp Lejeune Water Lawsuits Now Being Filed After President Biden Signed PACT Act
Camp Lejeune Water Lawsuits Now Being Filed After President Biden Signed PACT Act (Posted yesterday)

The President has signed the Camp Lejeune Justice Act into law as part of a larger package of veterans toxic chemical exposure health care benefits, which will allow those exposed to water contamination while living or serving on the base to file lawsuits against the federal government.